NO144147C - Analogifremgangsmaate for fremstilling av farmakologisk aktive prostaglandinderivater - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive prostaglandinderivater

Info

Publication number
NO144147C
NO144147C NO760994A NO760994A NO144147C NO 144147 C NO144147 C NO 144147C NO 760994 A NO760994 A NO 760994A NO 760994 A NO760994 A NO 760994A NO 144147 C NO144147 C NO 144147C
Authority
NO
Norway
Prior art keywords
ingrediates
prostagland
preparation
pharmacologically active
analogy procedure
Prior art date
Application number
NO760994A
Other languages
English (en)
Norwegian (no)
Other versions
NO760994L (ru
NO144147B (no
Inventor
Alain Jean
Charles Pigerol
Pierre Eymard
Jacques Simiand
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO760994L publication Critical patent/NO760994L/no
Publication of NO144147B publication Critical patent/NO144147B/no
Publication of NO144147C publication Critical patent/NO144147C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/16Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO760994A 1975-03-21 1976-03-19 Analogifremgangsmaate for fremstilling av farmakologisk aktive prostaglandinderivater NO144147C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB12034/75A GB1529852A (en) 1975-03-21 1975-03-21 8-azaprostaglandins and process for the preparation thereof

Publications (3)

Publication Number Publication Date
NO760994L NO760994L (ru) 1976-09-22
NO144147B NO144147B (no) 1981-03-23
NO144147C true NO144147C (no) 1981-07-15

Family

ID=9997230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO760994A NO144147C (no) 1975-03-21 1976-03-19 Analogifremgangsmaate for fremstilling av farmakologisk aktive prostaglandinderivater

Country Status (26)

Country Link
JP (1) JPS607602B2 (ru)
AR (1) AR213172A1 (ru)
AT (1) AT348163B (ru)
AU (1) AU501105B2 (ru)
BE (1) BE839761A (ru)
CA (1) CA1076587A (ru)
CH (2) CH611881A5 (ru)
DE (1) DE2612114A1 (ru)
DK (1) DK140937B (ru)
ES (2) ES446239A1 (ru)
FI (1) FI61692C (ru)
FR (1) FR2304340A1 (ru)
GB (1) GB1529852A (ru)
HU (1) HU173348B (ru)
IE (1) IE42966B1 (ru)
IT (1) IT1061011B (ru)
MX (1) MX3301E (ru)
NL (1) NL7602891A (ru)
NO (1) NO144147C (ru)
NZ (1) NZ180251A (ru)
OA (1) OA05279A (ru)
PT (1) PT64919B (ru)
SE (1) SE418290B (ru)
SU (1) SU614746A3 (ru)
YU (1) YU73876A (ru)
ZA (1) ZA761448B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds
US5540618A (en) * 1994-10-28 1996-07-30 National University Of Singapore Passive attenuator for shelter protection against explosions
WO2003074483A1 (fr) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif

Also Published As

Publication number Publication date
FR2304340A1 (fr) 1976-10-15
FI760744A (ru) 1976-09-22
GB1529852A (en) 1978-10-25
FI61692C (fi) 1982-09-10
JPS51138671A (en) 1976-11-30
DE2612114A1 (de) 1976-10-07
ES446239A1 (es) 1977-07-01
DK140937C (ru) 1980-05-19
FR2304340B1 (ru) 1979-06-29
ATA195676A (de) 1978-06-15
DK88276A (ru) 1976-09-22
PT64919A (en) 1976-04-01
CH611604A5 (en) 1979-06-15
OA05279A (fr) 1981-02-28
HU173348B (hu) 1979-04-28
ES458389A1 (es) 1978-02-16
IE42966B1 (en) 1980-11-19
BE839761A (fr) 1976-09-20
CA1076587A (en) 1980-04-29
AU1189976A (en) 1977-09-15
IT1061011B (it) 1982-10-20
YU73876A (en) 1982-10-31
PT64919B (en) 1977-08-24
JPS607602B2 (ja) 1985-02-26
NZ180251A (en) 1978-07-28
NO760994L (ru) 1976-09-22
MX3301E (es) 1980-09-03
IE42966L (en) 1976-09-21
AU501105B2 (en) 1979-06-14
CH611881A5 (en) 1979-06-29
NL7602891A (nl) 1976-09-23
AR213172A1 (es) 1978-12-29
SU614746A3 (ru) 1978-07-05
SE7603400L (sv) 1976-09-22
AT348163B (de) 1979-02-12
NO144147B (no) 1981-03-23
ZA761448B (en) 1977-03-30
FI61692B (fi) 1982-05-31
DK140937B (da) 1979-12-10
SE418290B (sv) 1981-05-18

Similar Documents

Publication Publication Date Title
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
SE431544B (sv) Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO149388C (no) Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO145197C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfolinforbindelser